Daniela Buti

695 total citations
8 papers, 428 citations indexed

About

Daniela Buti is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Clinical Biochemistry. According to data from OpenAlex, Daniela Buti has authored 8 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Psychiatry and Mental health, 3 papers in Pediatrics, Perinatology and Child Health and 3 papers in Clinical Biochemistry. Recurrent topics in Daniela Buti's work include Epilepsy research and treatment (6 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Metabolism and Genetic Disorders (3 papers). Daniela Buti is often cited by papers focused on Epilepsy research and treatment (6 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Metabolism and Genetic Disorders (3 papers). Daniela Buti collaborates with scholars based in Italy, Australia and United States. Daniela Buti's co-authors include Davide Mei, Renzo Guerrini, Carla Marini, Anna Rita Ferrari, Pierangelo Veggiotti, Federico Zara, Tiziana Granata, Charlotte Dravet, Evan Reid and J. Helen Cross and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Epilepsia and Pediatric Neurology.

In The Last Decade

Daniela Buti

8 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniela Buti Italy 6 331 179 136 112 78 8 428
Masako Sakauchi Japan 10 305 0.9× 123 0.7× 128 0.9× 165 1.5× 141 1.8× 18 503
Victoria Rodriguez‐Casero Australia 5 241 0.7× 177 1.0× 64 0.5× 142 1.3× 100 1.3× 7 380
Suha Mercho Canada 5 280 0.8× 173 1.0× 96 0.7× 182 1.6× 164 2.1× 6 459
Kristien Verhaert Belgium 5 168 0.5× 142 0.8× 54 0.4× 98 0.9× 62 0.8× 6 363
Sandra Sabbagh Lebanon 11 184 0.6× 68 0.4× 153 1.1× 118 1.1× 44 0.6× 30 369
Rosa Mostardini Italy 11 117 0.4× 138 0.8× 121 0.9× 96 0.9× 61 0.8× 22 349
Hideki Muranaka Japan 6 275 0.8× 86 0.5× 133 1.0× 218 1.9× 158 2.0× 13 416
Federica Teutonico Italy 10 272 0.8× 124 0.7× 152 1.1× 53 0.5× 124 1.6× 13 484
Beth Rosen Sheidley United States 11 316 1.0× 405 2.3× 116 0.9× 132 1.2× 61 0.8× 15 598
Hideyuki Ohtani Japan 8 240 0.7× 111 0.6× 108 0.8× 140 1.3× 135 1.7× 17 375

Countries citing papers authored by Daniela Buti

Since Specialization
Citations

This map shows the geographic impact of Daniela Buti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Buti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Buti more than expected).

Fields of papers citing papers by Daniela Buti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela Buti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Buti. The network helps show where Daniela Buti may publish in the future.

Co-authorship network of co-authors of Daniela Buti

This figure shows the co-authorship network connecting the top 25 collaborators of Daniela Buti. A scholar is included among the top collaborators of Daniela Buti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniela Buti. Daniela Buti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Mullen, Saul A., Carla Marini, Arvid Suls, et al.. (2011). Glucose Transporter 1 Deficiency as a Treatable Cause of Myoclonic Astatic Epilepsy. Archives of Neurology. 68(9). 1152–1152. 91 indexed citations
2.
Marini, Carla, Davide Mei, Teresa Temudo, et al.. (2007). Idiopathic Epilepsies with Seizures Precipitated by Fever and SCN1A Abnormalities. Epilepsia. 48(9). 1678–1685. 132 indexed citations
3.
Gennaro, Elena Di, Filippo M. Santorelli, Enrico Bertini, et al.. (2006). Somatic and germline mosaicisms in Severe Myoclonic Epilepsy of Infancy. Biochemical and Biophysical Research Communications. 341(2). 489–493. 83 indexed citations
4.
Bonanni, Paolo, Francesca Moro, Pierangelo Veggiotti, et al.. (2004). Generalized Epilepsy with Febrile Seizures Plus (GEFS+): Clinical Spectrum in Seven Italian Families Unrelated to SCN1A, SCN1B, and GABRG2 Gene Mutations. Epilepsia. 45(2). 149–158. 56 indexed citations
5.
Bernardina, Bernardo Dalla, Elena Fontana, Federico Vigevano, et al.. (1995). Efficacy and Tolerability of Vigabatrin in Children with Refractory Partial Seizures: A Single‐Blind Dose‐Increasing Study. Epilepsia. 36(7). 687–691. 30 indexed citations
6.
Battino, Dina, Daniela Buti, D. Croci, et al.. (1993). Lamotrigine in Resistant Childhood Epilepsy. Neuropediatrics. 24(6). 332–336. 31 indexed citations
7.
Battino, Dina, et al.. (1992). Lamotrigine (Lamictal®) in resistant childhood epilepsy. Pediatric Neurology. 8(5). 385–385. 1 indexed citations
8.
Favilli, Silvia, et al.. (1989). [Echocardiographic study of heart rhabdomyoma in tuberous sclerosis].. PubMed. 19(4). 319–23. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026